logo
welcome
PsyPost

PsyPost

Large-scale study links ketamine to lower risk of suicidal ideation in depression patients

PsyPost
Summary
Nutrition label

76% Informative

A recent study published in Translational Psychiatry found ketamine may significantly reduce suicidal thoughts in individuals with recurrent major depressive disorder ( MDD ) Those prescribed ketamine had a lower risk of developing suicidal ideation over the short and long term, up to 270 days following treatment, compared to those prescribed more common antidepressants.

Suicidal ideation, or thoughts of suicide, is common among those with MDD and poses a major public health concern.

“We will continue to monitor the risk and benefits of ketamine in real-world patients with MDD ,” Xu said. The study, “Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study,” was authored by Yiheng Pan , Maria P. Gorenflo , Pamela B. Davis , David C. Kaelber , Susan De Luca , and Rong Xu ..

VR Score

87

Informative language

94

Neutral language

45

Article tone

formal

Language

English

Language complexity

74

Offensive language

offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links